A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265).
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2015 |
| Author/s |
author: Georgina V. Long Eugenio Fernandez Josep Malvehy Igor Puzanov Jonathan Cebon F Stephen Hodi Antoni Ribas Reinhard Dummer Thomas F. Gajewski |
| Publication date | November 4, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |